IRCT20230222057495N12招募中Unknown
Bioequivalence study of famotidine 40 mg tablets of Ramopharmin pharmaceutical company compared to Famotidine 40 mg of Ratiopharm GmbH in Germany on healthy volunteers.
Ramopharmin Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy volunteer between 18 and 55 years old.
- •Body mass index less than 30 kg per square meter.
- •All candidates must be non-smokers.
排除标准
- •Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg.
- •Consumption of any drug, alcohol or tobacco within 2 weeks before receiving the drug
研究者
相似试验
招募中
Unknown
Bioequivalence study of famotidine 40 mg tablets produced by Actoverco pharmaceutical companyThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20240804062647N1?Actoverco Pharmaceutical Company24
已完成
不适用
Bioequivalance study of Famotidine 40 mgIRCT20200513047423N5Fatak chemie pars Pharmacy24
尚未招募
不适用
Bioequivalance study of Famotidine 40 mgSubject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.IRCT20200513047423N9Iran Daru Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tabletIRCT20210519051345N32Tabriz University of Medical Sciences24
尚未招募
不适用
Bioequivalence study of Famotidine 40 mgIRCT20200623047902N14Sanamed pharma company24